People with ties to Brownstone Institute have significant authority over access to vaccines and scientific research.

Invivyd is evaluating VYD2311 against an mRNA vaccine in Liberty (Slide 7), with a focus on safety differences. This is ...

Invivyd, Inc. advances VYD2311 as a Covid-19 vaccine alternative. Learn about upcoming trials and market opportunities. Click ...

RNA vaccine technology has emerged as a groundbreaking approach in the field of immunology and infectious disease prevention.

In a surprising discovery, a 'sticky molecule' that occurs naturally in our blood vessels could be both a culprit behind ...

The frozen remains of a juvenile woolly mammoth named Yuka preserved details about the animal’s last moments alive ...

For many people, COVID was not a short illness that faded with time. Months later, they still report fatigue, brain fog, ...

SHELTON, CONNECTICUT / ACCESS Newswire / November 14, 2025 / NanoViricides, Inc. (NYSE American:NNVC) (the “Company”), a clinical stage leader developing revolutionary broad-spectrum antiviral drugs ...

In other words, it’s a personalized cancer vaccine. Early tests of these vaccines are extremely promising. But the federal ...

Scientists have sequenced the oldest RNA from a 40,000-year-old mammoth named Yuka, unlocking genetic activity from its final ...

In a surprising discovery, a "sticky molecule" that occurs naturally in our blood vessels could be both a culprit behind ...

At the conference, Acuitas' Chief Scientific Officer, Dr. Ying Tam, showcased the company's Next-Generation LNP advancements, a comprehensive approach that uses multiple technologies and strategies to ...